Option Found for Retreatment of Chronic Hep C Infection
Glecaprevir + pibrentasvir effective for those who previously failed direct-acting antiviral treatment
CDC: Many Americans May Have Prediabetes and Not Know It
AMA, CDC launch a campaign to raise awareness about prediabetes
Name-Brand Medications Driving Spike in U.S. Drug Spending
Greatest costs for Humira, Remicade, Enbrel, Novolog, and Neulasta
Consensus Statement Issued on Management of Foot, Ankle Gout
Risk for gouty flares increased with use of thiazide diuretics, excessive alcohol intake
Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
For patients with prediabetes, changes in risk indicators during intervention tied to T2DM, CVD risk
Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
Intervention included educational deprescribing information to patients, physicians
One-Third of Peds Medication Errors Due to Usability Issues
EHR usability issues contribute to 36 percent of med errors; 18.8 percent may have caused harm
Denosumab Promising for TDT-Induced Osteoporosis Treatment
Higher percentage increase of L1 to L4 and wrist bone mineral density with DMN, reduction in pain
AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention
Second study shows no significant results for vitamin D supplementation versus placebo